The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but with fewer side effect…
Related Posts
Tecno Spark Go 1 Price in India Tipped; Design Renders, Key Features Surface Online
Tecno Spark Go 1 may be introduced soon in global markets and India. Details about the smartphone have started surfacing online. A report has shared […]
Mpox Virus Clade-2 Confirmed in Isolated Case in India, Health Ministry Activates Identification Protocols
The Health Ministry has confirmed an isolated case of Mpox virus Clade-2 in a patient who recently travelled from a country with ongoing Mpox transmission. […]
Tecno Pova 6 Neo 5G India Launch Date Set for September 11; Key Features Teased
Tecno Pova 6 Neo 5G will arrive in India soon. The company has now announced the launch date of the handset. Some key features of […]